Clinical trial

Reversibility of Methacholine Induced Bronchoconstriction

NCT05977699

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-01-12

PhasePHASE4

Study timeline

Study start (actual)2024-01-12Date precision: day

Registry last updated2026-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

salbutamol aqueous solutionDRUG

salbutamol pressurized metered dose inhalerDRUG

placeboOTHER

Sponsors & collaborators

University of Saskatchewanlead sponsor

Mapped research locations

SaskatoonSaskatchewan, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05977699 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.